Pritzker-backed Aurorium, a producer of pyridine and picolines, and specialty pyridine derivatives, completed the acquisition of CENTAURI Technologies, a technology driven manufacturing company. Financial terms were not disclosed. “CENTAURI is an exciting addition to Aurorium as we continue to expand our presence in specialty ingredients and materials. CENTAURI adds a complementary portfolio of high-quality solutions, differentiated manufacturing capabilities, and an impressive track record of innovation and growth. With CENTAURI’s customer-focused approach and exceptional engineering capabilities joining our platform, Aurorium is well-positioned to capitalize on growth across our end markets,” John Van Hulle, Aurorium CEO.